Stock URGN UROGEN PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions UroGen Pharma Ltd.

Equities

URGN

IL0011407140

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-03 pm EDT 		5-day change 1st Jan Change
14.3 USD +0.28% Intraday chart for UroGen Pharma Ltd. +1.06% -4.67%
Apr. 15 UroGen Pharma Says FDA Accepts Investigational New Drug Application for Potential Bladder Cancer Treatment MT
Apr. 03 UroGen Pharma Sues Teva Pharmaceuticals Over Alleged Patent Infringement of Jelmyto MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. URGN Stock
  4. Revisions UroGen Pharma Ltd.